Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33909455/
1 Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA. 2 Department of Hematology, University Hospital of Essen, Essen, Germany. 3 Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA. 4 Department Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
-
Mark FeslerMay 04, 2021This report makes clinical sense in that more clinically urgent cases, which often have aggressive features such as high disease bulk and advanced stage, would be associated with more circulating tumor